A new month has passed and many important activities are happening.
The IASLC nomination process is still open. We would like all the IASLC members to pay attention to the announcements for the new IASLC fellowships announced in this issue of the Newsletter and encourage as many applications as possible. The announcement is also translated in different languages and can be found on the IASLC web site (www.iaslc.org).
The IASLC welcomes our newly appointed Chief Editor for our Journal of Thoracic Oncology, Dr. Alex Adjei, who will succeed Dr. James Jett. With rapid developments in digital technologies new opportunities have arisen for our journal and our other educational activities. JTO will now also be available as an “app” for mobile devices.
We hope that those of you who have enjoyed summer season have had a good and healthy vacation period!
Many new things have recently happened within IASLC. IASLC has now been approved as a CME provider! That is a significant achievement for our organization and gives our Educational department much more flexibility in planning future activities.
Many important messages/announcements will be found in this Newsletter: The search for a new CEO for the organization has started and has been announced. As mentioned earlier, Dr. Paul Bunn Jr, MD, after many years in office, having brought this organization to another level, is stepping down at the WLCC in Sydney 2013. The IASLC Board is searching for his successor (see below). The search for a Chief Editor for our journal JTO is now in its final round.
We are proud to announce in this Newsletter the new IASLC Fellowship/Young Investigator Award winners. IASLC’s Fellowship/Young Investigators awards are important activities for our organization and many investigators have over the years been able to start very successful careers in lung cancer translational/clinical science through our awards.